Atossa Genetics (ATOS) IPO Trades Lower

November 8, 2012 11:30 AM EST
The IPO for Atossa Genetics (NASDAQ: ATOS) is trading at $4.70 per share after pricing 800,000 shares at $5.

Dawson James Securities, Inc. is the sole book-running manager for this offering.

Atossa Genetics, Inc., The Breast Health Company, is based in Seattle, Washington, and is focused on the prevention of breast cancer through the commercialization of diagnostic medical devices and tests that can detect precursors to breast cancer, and through research and development that will permit it to commercialize treatments for pre-cancerous lesions.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Add Your Comment